20 results on '"Perol, M."'
Search Results
2. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer: GFPC 99-01 study (Groupe français de pneumo-cancérologie)
3. P-941 Phase II study of gefitinib (IRESSA) administered as first linetreatment in patients with non-resectable, pneumonic-type adenocarcinoma (P-ADC)
4. P-320 Gefitinib therapy of advanced non small-cell lung cancer (NSCLC): A Markov model-based economic analysis
5. P-479 Expression of class III beta tubulin is predictive of patientoutcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy
6. O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer
7. Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial
8. Place of surgery in the treatment of small cell lung carcinoma. Report of a serie of 27 patients
9. Conformal radiotherapy as an alternative to surgery for respiratory inoperable stage I non-small cell lung cancer (NSCLC)
10. Phase II trial of high dose chemotherapy with amifostine and concurrent irradiation in limited disease small cell lung cancer (SCLC)
11. 156 Phase II study of docetaxel (Taxotere®) in 1st and 2nd line NSCLC
12. 125 The high pharmacokinetic variability of adriamycin, etoposide and ifosfamide among small cell lung cancer patients
13. 62 Phase II study of paclitaxel (Taxol®) and cisplatin (CDDP) in advanced pleural malignant mesothelioma (MM)
14. The limits of chemotherapy dose intensification using Granulocyte Colony Stimulating Factor alone in extensive small cell lung cancer
15. Cost analysis of hospital treatment—two chemotherapic regimens for non-surgical non-small cell lung cancer
16. Cost analysis of hospital treatment - two chemotherapic for non-surgical non-small cell lung cancer
17. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
18. Phase II with Taxol ® (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC)
19. Phase II with Taxol (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC)
20. Multicenter randomized phase II trial assessing docetaxel (D) alternating with cisplatin (C) and vinorelbine (V) versus cisplatin (C) - vinorelbine (V) in stage IV non-small-cell lung cancer (NSCLC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.